BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23691025)

  • 1. HPRT-deficiency dysregulates cAMP-PKA signaling and phosphodiesterase 10A expression: mechanistic insight and potential target for Lesch-Nyhan Disease?
    Guibinga GH; Murray F; Barron N
    PLoS One; 2013; 8(5):e63333. PubMed ID: 23691025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease.
    Göttle M; Prudente CN; Fu R; Sutcliffe D; Pang H; Cooper D; Veledar E; Glass JD; Gearing M; Visser JE; Jinnah HA
    Ann Neurol; 2014 Jul; 76(1):95-107. PubMed ID: 24891139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and neurobehavioral disturbances induced by purine recycling deficiency in
    Petitgas C; Seugnet L; Dulac A; Matassi G; Mteyrek A; Fima R; Strehaiano M; Dagorret J; Chérif-Zahar B; Marie S; Ceballos-Picot I; Birman S
    Elife; 2024 May; 12():. PubMed ID: 38700995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD metabolism in HPRT-deficient mice.
    Micheli V; Jacomelli G; Di Marcello F; Notarantonio L; Sestini S; Cerboni B; Bertelli M; Pompucci G; Jinnah HA
    Metab Brain Dis; 2009 Jun; 24(2):311-9. PubMed ID: 19319672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells from subjects with Lesch-Nyhan disease.
    Sutcliffe DJ; Dinasarapu AR; Visser JE; Hoed JD; Seifar F; Joshi P; Ceballos-Picot I; Sardar T; Hess EJ; Sun YV; Wen Z; Zwick ME; Jinnah HA
    Sci Rep; 2021 Apr; 11(1):8523. PubMed ID: 33875724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of neural stem cells in Lesch-Nyhan disease.
    Dinasarapu AR; Sutcliffe DJ; Seifar F; Visser JE; Jinnah HA
    J Neurogenet; 2022; 36(2-3):81-87. PubMed ID: 36226509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated generation of human embryonic stem cell sub-lines with HPRT1 gene knockout to model Lesch Nyhan disease.
    Boissart C; Chatrousse L; Poullion T; El-Kassar L; Giraud-Triboult K; Benchoua A
    Stem Cell Res; 2023 Sep; 71():103144. PubMed ID: 37331109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts.
    Escudero-Ferruz P; Ontiveros N; Cano-Estrada C; Sutcliffe DJ; Jinnah HA; Torres RJ; López JM
    Mol Med; 2024 Jan; 30(1):3. PubMed ID: 38172668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.
    Mencacci NE; Kamsteeg EJ; Nakashima K; R'Bibo L; Lynch DS; Balint B; Willemsen MA; Adams ME; Wiethoff S; Suzuki K; Davies CH; Ng J; Meyer E; Veneziano L; Giunti P; Hughes D; Raymond FL; Carecchio M; Zorzi G; Nardocci N; Barzaghi C; Garavaglia B; Salpietro V; Hardy J; Pittman AM; Houlden H; Kurian MA; Kimura H; Vissers LE; Wood NW; Bhatia KP
    Am J Hum Genet; 2016 Apr; 98(4):763-71. PubMed ID: 27058447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringin corrects renal failure related to Lesch-Nyhan disease in a rat model via NOS-cAMP-PKA and BDNF/TrkB pathways.
    Akintunde JK; Falomo IM; Akinbohun OM; Erinoso SO; Ugwor E; Folayan AD; Ateate AD
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23558. PubMed ID: 37865952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders.
    Sharma B; Bhattacherjee D; Zyryanov GV; Purohit R
    J Biomol Struct Dyn; 2023 Nov; 41(19):9424-9436. PubMed ID: 36336960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piezo1 stimulates mitochondrial function via cAMP signaling.
    Li X; Kordsmeier J; Nookaew I; Kim HN; Xiong J
    FASEB J; 2022 Oct; 36(10):e22519. PubMed ID: 36052712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very Early Levodopa May Prevent Self-Injury in Lesch-Nyhan Disease.
    Visser JE; Chorin O; Jinnah HA
    Pediatr Neurol; 2024 Jun; 155():156-159. PubMed ID: 38653184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKIB, a Novel Target for Cancer Therapy.
    Musket A; Moorman JP; Zhang J; Jiang Y
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wanted: A vocabulary for talking about involuntary behaviors associated with Lesch-Nyhan disease.
    Robey KL; Balboni DC
    JIMD Rep; 2021 May; 59(1):26-31. PubMed ID: 33977027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inborn Errors of Purine Salvage and Catabolism.
    Camici M; Garcia-Gil M; Allegrini S; Pesi R; Bernardini G; Micheli V; Tozzi MG
    Metabolites; 2023 Jun; 13(7):. PubMed ID: 37512494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Phosphodiesterase 10A Inhibitor PF-2545920 Enhances Hippocampal Excitability and Seizure Activity Involving the Upregulation of GluA1 and NR2A in Post-synaptic Densities.
    Zhang Y; Gao B; Zheng F; Lu S; Li Y; Xiong Y; Yang Q; Yang Y; Fu P; Xiao F; Wang X
    Front Mol Neurosci; 2017; 10():100. PubMed ID: 28439226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan Disease.
    Meek S; Thomson AJ; Sutherland L; Sharp MG; Thomson J; Bishop V; Meddle SL; Gloaguen Y; Weidt S; Singh-Dolt K; Buehr M; Brown HK; Gill AC; Burdon T
    Sci Rep; 2016 May; 6():25592. PubMed ID: 27185277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide salvage deficiencies, DNA damage and neurodegeneration.
    Fasullo M; Endres L
    Int J Mol Sci; 2015 Apr; 16(5):9431-49. PubMed ID: 25923076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic approach to Lesch-Nyhan disease.
    Dauphinot L; Mockel L; Cahu J; Jinnah HA; Ledroit M; Potier MC; Ceballos-Picot I
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):208-17. PubMed ID: 24940671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.